Primary Pulmonary Perivascular Epithelioid Cell Tumour (PEComa): A Case Report Authors: Yu Sugimoto, Takeshi Hanagiri, Syuhei Ashikari, Takashi Iwanami, Jongkun Park Published: 2025 ABSTRACT ABSTRACTPerivascular epithelioid cell tumour (PEComa) is a rare mesenchymal neoplasm; lung is an exceptional primary site. Herein, we present a surgically resected case of primary pulmonary PEComa and discuss its clinicopathologic features in comparison with previously published cases. A 47‐year‐old woman presented with a screening‐detected right lower lobe nodule. Computed tomography showed a 26‐mm S6 lesion abutting the A6. The patient underwent right S6 segmentectomy for diagnosis and treatment. The 30‐mm mass was well demarcated and pearly white; histology showed epithelioid cells with sinusoid‐like vasculature, rare mitoses and no necrosis. HMB45/Melan‐A was positive for focal smooth muscle actin, confirming the diagnosis of PEComa. The patient remained disease free for > 1 year under observation without adjuvant therapy. Although primary pulmonary PEComa is rare and typically indolent, reports of malignant behaviour justify vigilant long‐term surveillance and further case accumulation is warranted to refine the diagnostic criteria and management strategies.Keywords: HMB45, lung, Melan‐A, perivascular epithelioid cell tumour Introduction Perivascular epithelioid cell tumours (PEComas) are rare mesenchymal neoplasms. Among the various sites where PEComas can arise, primary pulmonary PEComas are extremely uncommon, with only a limited number of cases reported in the literature, particularly in Japan. Herein, we present a case of surgically resected primary pulmonary PEComa and discuss its clinicopathological features in comparison with previously published cases. Case Report A 47‐year‐old Filipino woman with a history of asthma was referred to our hospital after routine chest radiography revealed an abnormal shadow in the right middle lung field (Figure 1A). The patient was asymptomatic with no respiratory or systemic symptoms. Serum tumour markers, including carcinoembryonic antigen, squamous cell carcinoma, CYFRA and CA19‐9, were within normal limits. Contrast‐enhanced chest computed tomography (CT) revealed a well‐circumscribed, smooth, round nodule measuring 26 mm in maximum diameter in the right lower lobe S6 (Figure 1B). The lesion was located near the bifurcation of the segmental artery (A6) and compressed the adjacent pulmonary artery without clear radiological evidence of invasion. Preoperative bronchoscopy revealed no endobronchial tumours or obvious B6 stenosis. (A) Chest x‐ray showing a nodule measuring 25 mm in the right middle lung field. She had undergone annual routine chest radiography, but this lesion was pointed out for the first time on the current examination. (B) Contrast‐enhanced chest computed tomography showing a well‐circumscribed, smooth, round nodule (26 mm) in the right lower lobe of S6, closely abutting the A6 branch and compressing the pulmonary artery without clear evidence of invasion. (C) Gross photograph of the resected right S6 segment. The cut surface shows a well‐circumscribed, solid, pearly white mass measuring ~30 mm in maximum diameter. Although a benign lesion, such as a pulmonary hamartoma, was suspected, we elected to perform a right S6 segmentectomy for both diagnostic and therapeutic purposes. On the cut section, the tumour appeared as a well‐circumscribed, solid, pearly white mass measuring ~30 mm at the greatest diameter (Figure 1C). Microscopically, the tumour was composed of nests and sheets of epithelioid cells with clear‐to‐eosinophilic granular cytoplasm and distinct cell borders arranged around the sinusoid‐like vasculature. Mitotic figures were scarce, necrosis was absent and the tumour edges were pushing rather than infiltrating (Figure 2A,B). Immunohistochemically, the tumour cells were positive for HMB45 (Figure 2C) and Melan‐A (Figure 2D), with focal positivity for smooth muscle actin (SMA), supporting the diagnosis of PEComa. (A, B) Haematoxylin‐eosin staining (A: ×20, B: ×100). Nests and sheets of epithelioid cells with clear to weakly eosinophilic granular cytoplasm are interspersed with sinusoid‐like vasculature; nuclear atypia is mild and necrosis is absent. (C, D) Immunohistochemical staining (A: HMB45, B: Melan‐A; both ×200). Tumour cells are positive for HMB45 and Melan‐A. These melanocytic marker expressions support the diagnosis of PEComa. The postoperative course was uneventful. The chest drain was removed on postoperative day (POD) 2, and the patient was discharged on POD 12. The patient has been followed‐up without adjuvant therapy and has remained disease‐free for more than 1 year. Discussion PEComa is an uncommon mesenchymal tumour that more frequently arises in the uterus, kidney, gastrointestinal tract and retroperitoneum; therefore, the lung is a rare primary site [1]. Although PEComa has been reported more often in middle‐aged to older women [1, 2], some reports have suggested a slight male predominance when limited to pulmonary cases [3]. While the present case involved a Filipino patient, there are no data suggesting any ethnic or geographic predilection. Most patients are asymptomatic, and lesions are detected incidentally on imaging [4]; however, symptoms such as cough or back pain may appear when the diameter exceeds roughly 22 mm [5]. In the present case, although the tumour had a maximum diameter of 26 mm on CT, the patient was asymptomatic and the lesion was detected incidentally on screening imaging. According to the General Rule for Clinical and Pathological Record of Lung Cancer (8th edition, revised) [6], PEComatous tumours are categorised as non‐epithelial (mesenchymal) tumours of the lungs. Lesions with characteristic clinicopathologic features, namely clear cell tumour of the lung (‘sugar tumour’) and lymphangioleiomyomatosis, are distinguished from ‘conventional’ PEComa. There are currently no universally accepted diagnostic or therapeutic guidelines [7]. In practice, the diagnosis relies on histopathological findings supported by immunohistochemistry [5]; HMB45 and Melan‐A are typically positive, and SMA and TFE3 may also be expressed [1]. Among these, HMB45 is considered the most reliable marker. PEComas often show a perivascular growth pattern, and several pulmonary cases have been reported adjacent to pulmonary vessels [8, 9, 10]; in our case, the tumour abutted the segmental artery (A6). When a well‐circumscribed pulmonary nodule is in close contact with a vessel on CT, PEComa should be included in the differential diagnosis. Although most pulmonary PEComas follow a benign course, malignant behaviour has also been described [3]. Folpe et al. proposed six adverse histologic criteria—(1) size ≥ 5 cm, (2) infiltrative growth, (3) high cellularity, (4) mitotic rate ≥ 1/50 HPF, (5) moderate‐to‐high nuclear atypia and (6) necrosis—and suggested that meeting two or more indicates malignancy [11]. Applying these criteria by analogy to pulmonary lesions, our case (30 mm, non‐infiltrative, slightly increased cellularity, rare mitoses, minimal atypia and no necrosis) met only one criterion and was best regarded as benign. Although we did not obtain PET/CT images because a benign tumour was strongly suspected preoperatively, some reports have suggested that PET/CT may aid in risk stratification [12]. In addition, some PEComas are characterised by TFE3 rearrangements, which have been reported to be associated with a poorer prognosis than conventional cases [13]. Complete surgical resection is the treatment of choice for resectable pulmonary PEComa [5, 14, 15]; however, adjuvant therapy is generally unnecessary. Given the occasional reports of aggressive behaviour, careful long‐term follow‐up is required. Definitive radiotherapy should be considered in patients who are not candidates for surgery [16]. Furthermore, at the molecular level, many PEComas exhibit inactivation of the TSC1/TSC2 genes with consequent activation of the mTOR pathway, and the potential use of mTOR inhibitors as molecularly targeted therapy has been increasingly discussed in recent years [7]. In conclusion, we reported a surgically resected case of a primary pulmonary PEComa adjacent to a segmental pulmonary artery. Despite its rarity and generally indolent course, long‐term surveillance remains advisable, and further case accumulation is needed to refine the diagnostic and management strategies. Author Contributions Yu Sugimoto conceptualised the case report, performed a literature review and drafted the manuscript. Syuhei Ashikari and Takashi Iwanami collected clinical data. Takeshi Hanagiri and Jongkun Park supervised the study and approved its final version. All the authors critically revised the manuscript and approved its final submission. Funding The authors have nothing to report. Ethics Statement The authors have nothing to report. Consent The authors declare that written informed consent was obtained for the publication of this manuscript and accompanying images using the form provided by the Journal. The signed form is retained by the corresponding author and will be provided to the Journal upon request. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgements The authors have nothing to report. Sugimoto Y., Hanagiri T., Ashikari S., Iwanami T., and Park J., “Primary Pulmonary Perivascular Epithelioid Cell Tumour (PEComa): A Case Report,” Respirology Case Reports 13, no. 12 (2025): e70434, 10.1002/rcr2.70434. Associate Editor: Sita Andarini Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.